Summary of Research: Bullous Pemphigoid Burden of Disease, Management and Unmet Therapeutic Needs
This is a summary of the original review article “Bullous Pemphigoid: Burden of Disease, Management and Unmet Therapeutic Needs.” Bullous pemphigoid (BP) is a rare, chronic, autoimmune blistering disease that primarily affects older adults. It is a potentially life-threatening disease that can negatively impact patients’ quality of life. In this research summary, we provide an overview of this disease progression, how it can be diagnosed (including the diagnostic tools available), and what comorbidities might accompany it in this vulnerable population. In addition, we discuss the measures used to assess disease severity, as well as the standard-of-care treatment. Potential new biologics under investigation are also discussed.
Authors
- Dedee Frances Murrell (ORCID: https://orcid.org/0000-0003-2971-0199)
- Victoria P. Werth (ORCID: https://orcid.org/0000-0003-3030-5369)
- Marius Ardeleanu (ORCID: https://orcid.org/0000-0002-7712-6862)
- Pascal Joly (ORCID: https://orcid.org/0000-0002-8079-5004)
- Marc Yale (ORCID: https://orcid.org/0009-0006-6722-3569)
- Verena Hultsch
Institutions
- Inserm (FR)
- Regeneron (United States) (US)
- UNSW Sydney (AU)
- Cancer Trials Australia (AU)
- St George Hospital (AU)
- Philadelphia VA Medical Center (US)
- International Pemphigus & Pemphigoid Foundation (US)
- Université de Rouen Normandie (FR)
- University of Pennsylvania (US)
Publication Details
- Journal
- Dermatology and Therapy
- Published
- 2026-11-21
- DOI
- https://doi.org/10.1007/s13555-026-01972-y
- Primary Topic
- Autoimmune Bullous Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00